WHO ARE WE?

The goal of “Project Dontabhaktuni” is to support students and scientists all over the world who want to learn about drug development particularly in the area of clinical pharmacology and pharmacometrics. The mission of this nonprofit organization is to guide and empower budding scientists in achieving their career goals, by providing low-cost workshops, and access to mentoring programs which would lead to expedited drug development, appropriate drug therapy, and better patient outcomes.
​
In the last 3 years, 2000 PhD and PharmD Scientists from 40 countries around the world have participated in workshops hosted by “Project Dontabhaktuni”. This overwhelming response has been encouraging and yet it is evident that there is a big void between supply and demand. We are seeing a thirst for knowledge in the scientific communities around the world, especially in developing countries like India, South America, many African countries, and China. Scientists yearn to learn more about clinical pharmacology and pharmacometrics and yet, there are not many avenues where these courses are being offered. We are addressing this demand and would like to continue to do so and hope to expand our reach.​
Our Workshops in 2023
Our Workshops in 2022
Our Workshops in 2021​

3-months Hands-on Workshop in Pharmacometrics​

​​​This workshop covered the fundamentals of Pharmacometrics and PK/PD modeling, a practical introduction to the R environment and will enable delegates to achieve confidence and proficiency in R with specific reference to pharmacometrics modelling using RsNLME - Certara’s new biosimulation tool.
Picture
Total number of participants: 111

The Method of Averaging Applied to PK/PD Modeling​

The computational effort required to fit the PD part of a PK/PD model can be considerable if the differential equations describing the model are solved numerically using Method of Averaging (MoA). This workshop explained the basis of the MoA by means of a simple mathematical derivation.
Picture
Total number of participants: 167

Role of Model-Informed Drug Development​

Most new compounds fail in drug development before ever reaching the market.  The high cost of new drugs is driven by this high attrition rate.  This workshop discussed how quantitative methods, including modeling and simulation, can help address this challenge. This workshop will provide examples of the application of MIDD with a focus on the impact on trial design and development strategy. 
Picture
Total number of participants: 147

Our Workshops in 2020 

R for Pharmacometrics
​

​​In October and November 2020, we hosted a two-day beginner workshop titled “R for Pharmacometrics” by Dr. Surulivel Rajan Mallayasamy, Associate Professor of Pharmaceutical Sciences at Manipal College, in Manipal, India. This was a live hands-on course with over 70 registrations from around the world​​

​Role of Clinical Pharmacology-Discovery to Approval

In August and Septem​ber 2020, we hosted a two-day workshop on “Role of Clinical Pharmacology-Discovery to Approval” by Dr. Partha Nandy, Senior Director of Clinical Pharmacology and Pharmacometrics at Johnson and Johnson, which we cohosted with SSX India.  At those two workshops and had over 550 registrations from around the world​​​
Picture
This workshop was attended by 540 participants

Introduction to RxODE ​​

In July 2020 we hosted a two-day hands-on Tutorial presenting the application of an R package, “A Brief Introduction of Pharmacometrics Simulation with RxODE” by Dr. Wenping Wang, Senior Director Pharmacometrics at Novartis, in collaboration with ISOP. We received an overwhelming response and had about 500 scientists from around the world​. 
Picture
This workshop helped 500 participants
Our Workshops in 2019 ​

In 2019, we visited China and India and hosted workshops in several universities.  We had over 500 scientists taken advantage of our workshops in that region.

OUR GOAL

​Empower budding drug development scientists from around the world